These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 160)

  • 1. Fluorometric assay for N-acetylprocainamide.
    Matusik E; Gibson TP
    Clin Chem; 1975 Dec; 21(13):1899-902. PubMed ID: 160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of the EMIT procainamide and N-acetylprocainamide assay.
    Walberg CB; Wan SH
    Ther Drug Monit; 1979; 1(1):47-56. PubMed ID: 95422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme immunoassay, liquid chromatography, and spectrofluorometry compared for the determination of procainamide and N-acetylprocainamide in serum.
    Pape BE
    J Anal Toxicol; 1982; 6(1):44-8. PubMed ID: 6176781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High performance liquid chromatography of procainamide and N-acetylprocainamide in human blood plasma.
    Raphanaud D; Borensztejn M; Dupeyron JP; Guyon F
    Ther Drug Monit; 1986; 8(3):365-7. PubMed ID: 2428144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of procainamide and N-acetylprocainamide in serum by high-performance liquid chromatography.
    Shukur LR; Powers JL; Marques RA; Winter ME; Sadée W
    Clin Chem; 1977; 23(4):636-8. PubMed ID: 844158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of procainamide and N-acetylprocainamide in biological fluids by high-pressure liquid chromatography.
    Lai CM; Kamath BL; Look ZM; Yacobi A
    J Pharm Sci; 1980 Aug; 69(8):982-4. PubMed ID: 6157019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of plasma procainamide and N-acetylprocainamide concentration by high-pressure liquid chromatography.
    Dutcher JS; Strong JM
    Clin Chem; 1977 Jul; 23(7):1318-20. PubMed ID: 872378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous quantification of procainamide and N-acetylprocainamide with high-performance liquid chromatography.
    Carr K; Woosley RL; Oates JA
    J Chromatogr; 1976 Dec; 129():363-8. PubMed ID: 1002795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence photometric quantitation of procainamide and N-acetylprocainamide in plasma after separation by thin-layer chromatography.
    Gupta RN; Eng F; Lewis D
    Anal Chem; 1978 Feb; 50(2):197-9. PubMed ID: 623381
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of Fluoroimmunoassays for the determination of individual or combined levels of procainamide and N-acetylprocainamide in serum.
    Al-Hakiem MH; Smith DS; Landon J
    J Immunoassay; 1982; 3(1):91-110. PubMed ID: 6182162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous quantitation of quinidine, procainamide, and N-acetylprocainamide in serum by gas-liquid chromatography with a nitrogen-phosphorus selective detector.
    Kessler KM; Ho-Tung P; Steele B; Silver J; Pickoff A; Narayanan S; Myerburg RJ
    Clin Chem; 1982 May; 28(5):1187-90. PubMed ID: 6176367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoroimmunoassays for procainamide and N-acetylprocainamide compared with a liquid-chromatographic method.
    MacKichan JJ; Coyle JD; Shields BJ; Boudoulas H; Lima JJ
    Clin Chem; 1984 May; 30(5):768-73. PubMed ID: 6201304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of N-acetylprocainamide.
    Connolly SJ; Kates RE
    Clin Pharmacokinet; 1982; 7(3):206-20. PubMed ID: 6178545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More-sensitive enzyme-multiplied immunoassay technique for procainamide and N-acetylprocainamide in plasma, serum, and urine.
    Henry PR; Dhruv RA
    Clin Chem; 1988 May; 34(5):957-60. PubMed ID: 2453309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High performance liquid chromatographic method for determination of procainamide and its active metabolites, N-acetylprocainamide in serum].
    Zhang SQ; Olugo-Edege GC; Zhu YP; Mao FF; An DK
    Yao Xue Xue Bao; 1988 Jun; 23(6):430-4. PubMed ID: 2463733
    [No Abstract]   [Full Text] [Related]  

  • 16. Assay of serum procainamide and N-acetylprocainamide: a comparison of emit and reverse-phase high-performance liquid chromatography.
    Griffiths WC; Dextraze P; Hayes M; Mitchell J; Diamond I
    Clin Toxicol; 1980 Mar; 16(1):51-4. PubMed ID: 6156051
    [No Abstract]   [Full Text] [Related]  

  • 17. Elimination of procainamide in end stage renal failure.
    Gibson TP; Lowenthal DT; Nelson HA; Briggs WA
    Clin Pharmacol Ther; 1975 Mar; 17(3):321-9. PubMed ID: 1120398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter: Fluorometric or gas-liquid chromatographic determination of procainamide?
    Frislid K; Bredesen JE; Lunde PK
    Clin Chem; 1975 Jul; 21(8):1180-2. PubMed ID: 1137928
    [No Abstract]   [Full Text] [Related]  

  • 19. Determination of procainamide and N-acetylprocainamide by "high-performance" liquid chromatography.
    Stearns FM
    Clin Chem; 1981 Dec; 27(12):2064-7. PubMed ID: 6171366
    [No Abstract]   [Full Text] [Related]  

  • 20. Thin-layer chromatographic determination of procainamide and N-acetylprocainamide in human serum and urine at single-dose levels.
    Kark B; Sistovaris N; Keller A
    J Chromatogr; 1983 Oct; 277():261-72. PubMed ID: 6196373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.